(877) 330-2919
Have multiple conditions? Click here
Select your condition
Tell us what's ailing you or use the guide to select multiple conditions
Choose your location
Enter your Zip Code into the guide or click on a state to find trials near you
Speak to an expert
The quickest way to get started! Get instantly connected to the right trial

Clinical Trials in Michigan (MI) | Michigan Clinical Drug Trials & Studies

You are viewing Clinical Trials In Michigan
Have multiple conditions? Click here

Showing 1-100 of 3403
There are 3403 trials in Michigan
Name City State Zip
Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Ypsilanti MI 48197
Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Ypsilanti MI 48197
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis Ypsilanti MI 48197
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers Ypsilanti MI 48197
Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma Wyoming MI 49519
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Wyoming MI 49519
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Wyoming MI 49519
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Wyoming MI 49519
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection Wyoming MI 49519
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Wyoming MI 49519
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Wyoming MI 49519
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Wyoming MI 49519
Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Wyoming MI 49519
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Wyoming MI 49519
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Wyoming MI 49519
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma Wyoming MI 49519
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery Wyoming MI 49519
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Wyoming MI 49519
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Wyoming MI 49519
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Wyoming MI 49519
Acute Pain Caused by Paclitaxel in Patients With Cancer Wyoming MI 49519
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer Wyoming MI 49519
Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Wyoming MI 49519
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Wyoming MI 49519
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer Wyoming MI 49519
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Wyoming MI 49519
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery Wyoming MI 49519
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary Wyoming MI 49519
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Wyoming MI 49519
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Wyoming MI 49519
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Wyoming MI 49519
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Wyoming MI 49519
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer Wyoming MI 49519
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Wyoming MI 49519
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers Wyoming MI 49519
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma Wyoming MI 49519
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Wyoming MI 49519
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Wyoming MI 49519
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Wyoming MI 49519
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Wyoming MI 49519
RO4929097 in Treating Patients With Stage IV Melanoma Wyoming MI 49519
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Wyoming MI 49519
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Wyoming MI 49519
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Wyoming MI 49519
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI West Bloomfield MI 48322
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease West Bloomfield MI
Developing an Intervention to Address Suicide Risk During Substance Use Disorder Waterford MI 48327
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Warren MI 48093
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Warren MI 48093
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Warren MI 48093
Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia Warren MI 48093
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Warren MI 48093
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Warren MI 48093
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Warren MI 48093
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Warren MI 48093
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma Warren MI 48093
VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer Warren MI 48093
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Warren MI 48093
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Warren MI 48093
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Warren MI 48093
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Warren MI 48093
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer Warren MI 48093
Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Warren MI 48093
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Warren MI 48093
Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery Warren MI 48093
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Warren MI 48093
Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct Warren MI 48093
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery Warren MI 48093
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Warren MI 48093
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Warren MI 48093
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Warren MI 48093
Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia Warren MI 48093
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer Warren MI 48093
Acute Pain Caused by Paclitaxel in Patients With Cancer Warren MI 48093
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer Warren MI 48093
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Warren MI 48093
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Warren MI 48093
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer Warren MI 48093
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma Warren MI 48093
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Warren MI 48093
Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma Warren MI 48093
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Warren MI 48093
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Warren MI 48093
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary Warren MI 48093
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Warren MI 48093
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Warren MI 48093
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Warren MI 48093
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer Warren MI 48093
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer Warren MI 48093
Home-Based Programs for Improving Sleep in Cancer Survivors Warren MI 48093
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers Warren MI 48093
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma Warren MI 48093
Study of Tissue and Blood Samples From Patients With High-Grade Glioma Warren MI 48093
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Warren MI 48093
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Warren MI 48093
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Warren MI 48093
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma Warren MI 48093
Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery Warren MI 48093
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer Warren MI 48093
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma Warren MI 48093
View Clinical Trial Facilities in Michigan

Showing 1-100 of 3403
browse trials by condition
helpful resources
share this page


Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
Featured Locations: Anaheim - Atlanta - Birmingham - Cleveland - DeLand - Jacksonville - Miami - Oklahoma City
About Us | Contact Us | Privacy Policy | Terms of Service | Sitemap
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Fill out the information below to find the right trial
Step 1: Contact Information
Step 2: Tell Us About Yourself



Do You Smoke
Can you stay overnight?
*Some trials require overnight observation
Step 3: Find Trials for the Following Conditions (choose all that apply)
  • Cardiology / Vascular Diseases






  • Dental / Maxillofacial Surgery

  • Dermatology / Plastic Surgery






  • Endocrinology





  • Gastroenterology








  • Hematology




  • Immunology / Infectious Diseases








  • Musculoskeletal




  • Nephrology / Urology






  • Neurology





  • Oncology












  • Ophthalmology

  • Orthopedics / Podiatry



  • Other



  • Otolaryngology


  • Pharmacology / Toxicology


  • Psychiatry / Psychology






  • Pulmonary / Respiratory Diseases








  • Reproductive






  • Rheumatology








Yes, please send me updates about the latest trials in my area

Thanks for submitting your information!
You will be contacted by one of our Clinical Trials Specialists to help guide you through the process of finding the right trial for you!
Based on your responses, we have a few additional questions (optional):
Login
Forgot password?
Enter your email and we will resend your password
Register
Change Password